title: The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study.
authors.forename: B
authors.initials: B
authors.lastname: Pitt
authors.forename: G
authors.initials: G
authors.lastname: Williams
authors.forename: W
authors.initials: W
authors.lastname: Remme
authors.forename: F
authors.initials: F
authors.lastname: Martinez
authors.forename: J
authors.initials: J
authors.lastname: Lopez-Sendon
authors.forename: F
authors.initials: F
authors.lastname: Zannad
authors.forename: J
authors.initials: J
authors.lastname: Neaton
authors.forename: B
authors.initials: B
authors.lastname: Roniker
authors.forename: S
authors.initials: S
authors.lastname: Hurley
authors.forename: D
authors.initials: D
authors.lastname: Burns
authors.forename: R
authors.initials: R
authors.lastname: Bittman
authors.forename: J
authors.initials: J
authors.lastname: Kleiman
mesh_terms: D000450:Aldosterone / Q000097:blood; D004311:Double-Blind Method; D000077545:Eplerenone; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000150:complications*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D018401:Sample Size; D013148:Spironolactone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D016019:Survival Analysis; D013599:Systole
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000450:Aldosterone; D000077545:Eplerenone